MedPath

辽宁药联制药有限公司

Ownership
-
Established
2008-05-12
Employees
-
Market Cap
-
Website
www.lnylzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

72

NMPA:72

Drug Approvals

Potassium Aspartate Tablets

Product Name
门冬氨酸钾片
Approval Number
国药准字H20140086
Approval Date
Apr 1, 2024
NMPA

Loratadine Effervescent Tables

Product Name
氯雷他定泡腾片
Approval Number
国药准字H20083702
Approval Date
Mar 22, 2023
NMPA

天沈牌林蛙油维生素E软胶囊

Approval Number
国食健注G20180008
Approval Date
May 19, 2022
NMPA

Potassium Aspartate

Product Name
门冬氨酸钾
Approval Number
国药准字H20123305
Approval Date
Apr 27, 2022
NMPA

Protionamide

Product Name
丙硫异烟胺
Approval Number
国药准字H20113331
Approval Date
Aug 20, 2021
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20163345
Approval Date
Aug 18, 2021
NMPA

Sodium Gluconate

Product Name
葡萄糖酸钠
Approval Number
国药准字H20060670
Approval Date
Jan 7, 2021
NMPA

Potassium Aspartate Injection

Product Name
门冬氨酸钾注射液
Approval Number
国药准字H20110032
Approval Date
Jan 7, 2021
NMPA

Potassium Aspartate Injection

Product Name
门冬氨酸钾注射液
Approval Number
国药准字H20133001
Approval Date
Jan 7, 2021
NMPA

Etofylline Clofibrate Tablets

Product Name
益多酯片
Approval Number
国药准字H21021399
Approval Date
Sep 2, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.